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Abstract 
Purpose: To identify and quantify the main concepts included in published studies 
focusing on individuals with schizophrenia using the International Classification of 
Functioning, Disability and Health (ICF).  
Methods: Searches (limited to those published from 2008 to 2012) were performed in 
Medline, PsycINFO and CINAHL. Included studies described participants with 
schizophrenia, were original articles, and included only subjects who were at least 18 
years of age at study entry. All concepts underlying the measures and the text of the 
articles were extracted, and they were linked to ICF categories using standardized rules.  
Results: From the 3,584 abstracts retrieved, 348 were randomly selected, and of these, 
206 studies met the inclusion criteria. A total of 17,141 concepts were extracted, 84.8% 
of which could be linked to 491 ICF categories: 222 (45.21%) of the categories referred 
to Body Functions, 29 (5.91%) to Body Structures, 186 (37.88%) to Activities and 
Participation and 54 (11%) to Environmental Factors. Seventy second-level categories 
were reported in at least 5% of all studies: 30 of these categories referred to Body 
Functions, 2 to Body Structures, 34 to Activities and Participation and 4 to  
Environmental Factors. 
Conclusion: The study has allowed us to identify and quantify the main concepts 
included in studies focusing on people with schizophrenia using the ICF. The majority 
of the concepts refer to Body Functions and Activities and Participation, rather than to 
Body Structures and Environmental Factors. 
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Functioning in patients with schizophrenia: A systematic review of the literature 
using the International Classification of Functioning, Disability and Health (ICF) 
as a reference 
 
Introduction 
Schizophrenia is a chronic and relapsing disorder characterized by positive and negative 
symptoms, variable social and cognitive impairment, disorganization, a high prevalence 
of substance use disorders, and increased mortality [1]. In fact, it is ranked among the 
top 20 most disabling diseases, with a prevalence of 26.3 million people worldwide [2]. 
Diminished functioning and low health-related quality of life (HRQOL) have 
consistently been reported as being associated with schizophrenia [3, 4 , 5]. More 
specifically, both functioning and HRQOL are affected by negative symptoms and by 
the side effects of some antipsychotics, among other factors [3, 6]. Before proceeding, it 
will be helpful to clarify our use of these terms in this article, since although functioning 
and HRQOL are not synonymous, they are certainly related. Thus, whereas functioning 
and disability reflect the objective perspective of health and health-related domains, 
HRQOL can be defined as an individual’s perceptions of these domains [7]. Hence, 
from an objective perspective, functioning can be classified into meaningful and 
discrete elements or categories, and these same categories may serve as the starting 
point for the operationalization and, therefore, the assessment of people’s subjective 
experience [7]. Consequently, an in-depth understanding of the outcome domains that 
have been addressed in studies of schizophrenia would help to better assess the impact 
of this disorder on individuals’ functioning and HRQOL. In this regard, Bromley and 
Brekke [8] have suggested that assessing the functioning of persons with schizophrenia 
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is crucial for a better understanding of the course of the disease, the potential impact of 
treatment and the rehabilitation outcomes. 
The International Classification of Functioning, Disability and Health (ICF [9]) 
provides a comprehensive and universally accepted framework to classify and describe 
functioning, disability and health in people with all kinds of diseases” [10, p. 306]. It is 
structured hierarchically in chapters and categories of different levels, and functioning is 
described based on four components: Body Functions, Body Structures, Activities and 
Participation and Environmental Factors. An example from the component Body 
Structures is as follows: s1: Structures of the nervous system (1 st level); s110 Structure 
of brain (2nd level); s1100: Structure of cortical lobes (3 rd level); s11000: Frontal lobe 
(4th level). 
The ICF is a comprehensive classification containing more than 1400 categories. 
However, the large number of categories poses a major challenge in terms of 
practicability and feasibility, and not all the categories will be relevant to each specific 
health condition. Thus, in order to enhance the applicability of the classification and 
tailor it to the needs of users, ICF Core Sets (ICF-CSs) have been proposed for several 
health conditions [11]. These ICF-CSs cover the most relevant categories for a specific 
health condition and allow both clinicians and researchers to classify and describe 
functioning using an international and common terminology [12]. There are 
comprehensive and brief versions of the ICF-CSs. The Comprehensive ICF-CS for a 
specific health condition includes as few categories as possible to be practical, but as 
many as necessary to be sufficiently comprehensive when seeking to describe the 
typical spectrum of problems in functioning and in the environment of individuals with 
that condition. The Brief ICF-CS is a shorter list of ICF categories derived from the 
Comprehensive ICF-CS for the same condition. The categories selected are those 
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considered to be essential for describing the typical spectrum of limitations in 
functioning and in the environment of affected individuals, while at the same time being 
few enough in number to be practical in clinical studies or trials [13]. For clinical 
practice and research, ICF-CSs may serve as a practical tool that covers the entire 
spectrum of functioning of persons with a specific health condition, and they can be 
used in documenting, reporting and assessing the impact of that health condition on a 
person’s lived experience worldwide [11, 14]. 
Under the methodology endorsed by the WHO [11] for developing an ICF-CS a number 
of perspectives need to be gathered and integrated into the development process, which 
can be divided into a preparatory phase and a consensus conference. The aim of the 
preparatory phase is to consider the perspectives of patients (see, for example [15, 16]), 
health professionals (for example [17, 18]), experts (for example [19, 20]) and 
researchers (for example [21, 22, 23]), and to identify the aspects of functioning and 
health that they each believe to be relevant. Since ICF-CSs are designed to be used in 
both clinical and research settings, it is important to ensure that both these perspectives 
have been taken into account in the development process. One way of ascertaining the 
views of researchers and the topics that are relevant to their work is to systematically 
review the outcomes that are measured and reported in research on a given health 
condition. In order to do this within the framework of the ICF, one must first identify 
the concepts reported in published studies, link these concepts to the ICF and analyse 
quantitatively the ICF categories. 
In the case of schizophrenia, the ICF-CS development project began in 2013 as a 
collaboration between the University of Barcelona and the ICF Research Branch, a 
cooperation partner within the WHO Collaborating Centre for the Family of 
International Classifications. The preparatory phase was conducted between 2013 and 
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2015. The current study presents the results from the systematic literature review, which 
enabled us 1) to identify the aspects of functioning in schizophrenia which have been 
mostly widely examined in the scientific literature, and to detect those which have been 
neglected or less widely studied, and 2) to incorporate the research perspective into the 
process of developing the ICF-CS for schizophrenia, thus providing a complement to 
the perspectives of patients, health professionals and experts. The availability of the 
ICF-CS for schizophrenia based on a widely accepted terminology will help to support 
clinical practice, for instance, in planning interventions or defining rehabilitation goals 
and patient care, and will also contribute to health reporting and research.  
In light of the above, the aims of this systematic review were 1) to identify relevant 
outcomes reported in published studies of individuals with schizophrenia, and 2) using 
the ICF as a conceptual framework, to identify and quantify the concepts addressed in 
these outcome variables.  
Methods 
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 
guidelines were followed in reporting this systematic review [24]. 
Study design 
The systematic review involved three steps. First, studies were selected from different 
electronic databases. Second, concepts present in the measures and in the full text were 
extracted from the included studies. Finally, the concepts underlying the outcome 
variables were linked to the corresponding ICF categories. All three steps were carried 
out by two independent reviewers in accordance with the methodology that has been 
developed and implemented for these purposes by the ICF Research Branch, Nottwil, 
Switzerland (www.icf-research-branch.org), a cooperation partner within the WHO 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Collaborating Centre for the Family of International Classifications in Germany (at the 
German Institute of Medical Documentation and Information),. 
Search strategy and inclusion criteria (Step 1) 
We conducted electronic searches of MEDLINE, PsycINFO and the Cumulative Index 
to Nursing and Allied Health Literature (CINAHL) for the period 2008 to 2012, using 
the following search terms and strategy: schizophren* AND (function* OR disab*) 
located in the Title, Abstract or Keywords fields. All searches were limited to English-
language, peer-reviewed articles referring to studies conducted with human participants. 
Due to the very large number of abstracts retrieved by the search, only a random sample 
of these was ultimately checked for inclusion. Assuming a finite population, simple 
random sampling was performed. Sample size was defined according to the primary 
binary outcome variable (sample error 5%; confidence level 95%; p = q = .5).  
The eligibility criteria applied when checking these abstracts were as follows: (1) 
describing participants with schizophrenia, and excluding studies with first-episode 
psychosis patients and post-mortem studies; (2) original journal articles (randomized 
controlled trials, randomized clinical trials, controlled clinical trials, cross-sectional 
studies, longitudinal observational studies, qualitative studies, and case reports), and 
excluding meta-analysis, reviews, psychometric studies, preventive studies (healthy 
study population), studies of phase-II clinical trials and studies with exclusive 
laboratory parameters; and (3) including only subjects who are at least 18 years of age 
at study entry, and excluding studies of children and adolescents.  
Data extraction procedure (Step 2) 
Two psychologists specialized in schizophrenia independently extracted the underlying 
concepts present in the measures (standardized questionnaires) and the full text of each 
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article; they also recorded the most relevant characteristics of the selected studies. In the 
event that an article did not specify the items of a given questionnaire, we sought to 
obtain this information either by checking the original references for the instrument or 
through internet searches.  
Study characteristics such as study type (observational, intervention, other), sample size 
(<10, 10-50, 51-100, >100), type of diagnosis (schizophrenia alone, schizophrenia 
spectrum disorders [e.g. schizoaffective or schizophreniform disorders], concomitant 
pathologies), diagnostic criteria used, type of sample (inpatient, outpatient, mixed), time 
in years since diagnosis, number of patients, age range and mean age of patients, and 
gender of sample (male, female, mixed) and percentage of males were documented. 
After identifying the underlying concepts, the two researchers compared their results 
and resolved any disagreement by discussion.  
Linking to the ICF (Step 3) 
The identified concepts were then linked to the most specific ICF category, this being 
done separately by two trained researchers with experience of the ICF and in 
accordance with linking rules developed for this purpose [25] (see Table 1 for 
examples). For standardized questionnaires, the same linking rules were used to link the 
concepts present in the extracted items to the ICF. The ICF categories obtained by the 
two independent researchers were then compared, and in the event of disagreement a 
consensus was reached by discussion. The inter-rater reliability between the two 
researchers, based on the overall percentage of agreement, was also calculated. The 
value obtained was .80 (95% CI .79-.81). When the information provided by a concept 
was not sufficient for making a decision about an ICF category, it was linked using the 
code “not definable (nd)”. If a concept did not appear in the ICF but was clearly a 
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personal factor as defined in the ICF1, it was coded as “personal factor” (pf). When a 
concept was not represented by the ICF categories, it was coded as “not covered” (nc). 
Finally, when a concept referred to a diagnosis or a health condition it was coded as 
“health condition” (hc) [26]. Examples of the coding of concepts are as follows: “level 
of functioning” was coded as “nd_functioning”, “age at onset” was coded as “pf_age at 
onset”, “suicide attempt” was coded as “nc_suicide”, and “schizophrenia diagnosis” was 
coded as “hc_schizophrenia”.  
Insert Table 1 about here 
Data analysis 
Absolute and relative frequencies of the ICF categories linked to the identified concepts 
were calculated, relative to the total number of studies. Given that we used a random 
sample of all the articles identified in the literature search, we report the 95% 
confidence intervals of these percentages. In order to avoid bias, any ICF category that 
was assigned repeatedly in a given study was counted only once. Only ICF categories 
with a frequency equal to or greater than 5% were reported. ICF categories are 
presented at the first and second level. “If a concept was linked to a third- or fourth-
level category, the corresponding second-level category was reported, as lower-level 
categories share the attributes of the higher-level category” [23, p. 809]. For example, 




1 Personal factors refer to the particular background of an individual’s life and circumstances and comprise features of the 
individual that are not part of a health condition or health states (e.g. gender, race, age, other health conditions, fitness , lifestyle, 
habits, etc.) [9]. 
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In the first step 3,584 studies were located using the electronic search strategy. Of these, 
348 were randomly selected and 206 met the inclusion criteria for final selection. 
Therefore, the full text of those 206 articles was assessed (See Appendix 1 for the full 
list of included papers). The selection process is illustrated in Figure 1. The most 
frequent exclusion criteria were that the participants were not patients with 
schizophrenia (57% of excluded studies) or that they were first-episode psychosis 
patients (21.5% of excluded studies).  
Insert Figure 1 about here 
Most studies had an observational design (79.6%) and the majority of them had been 
conducted with outpatients (31.1%). The main diagnosis was schizophrenia alone 
(66.0%), and diagnoses were mostly based (77.2%) on criteria of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM). The time since diagnosis ranged from 6 
months to 41 years (Median = 12 years; Interquartile Range [IQR] = 9-15 years). The 
number of participants ranged from 1 to 5134 (Median = 50; IQR = 21-113). Mean age 
ranged from 19 to 67.7 years (Median = 36.3; IQR = 32.58-41) and the percentage of 
males ranged from 0 to 100% (Median = 63.58; IQR = 53.11-73.20%). The study 
characteristics are shown in Table 2. 
Insert Table 2 about here 
A total of 17,141 concepts were identified in the 206 studies. Of these, 10,785 concepts 
(62.9%) were identified in the measurement instruments used in the studies. The 
instruments most frequently used were the Positive and Negative Syndrome Scale 
(PANSS [27]) (used in 55.8% of the articles), the Wechsler Adult Intelligence Scale 
(WAIS [28]) (used in 20.9% of the articles) and the Wisconsin Card Sorting Test 
(WCST [29]) (used in 15% of the articles). Eight hundred and fourteen concepts (4.7%) 
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were considered as not definable, 448 concepts (2.6%) as personal factor, 440 concepts 
(2.6%) as not covered and 901 concepts (5.3%) as health condition. The remaining 
14,538 concepts (84.8%) were able to be linked to a total of 491 ICF categories. These 
concepts were linked to 182 second-level ICF categories (37.1%), 286 third-level ICF 
categories (58.2%) and 23 fourth-level ICF categories (4.7%).  
Table 3 shows the first-level categories that were addressed in at least 5% of all studies. 
This includes 7 out of 8 Body Functions chapters, 2 out of 7 Body Structures chapters, 
all 9 Activities and Participation chapters and 3 out of 5 Environmental Factors 
chapters.  
Aggregating the second-, third- and fourth-level categories at the second level yielded 
202 different second-level categories: 74 out of 114 (64.9%) were linked to Body 
Functions categories, 15 out of 56 (26.8%) to Body Structures categories, 83 out of 118 
(70.3%) to Activities and Participation categories and 30 out of 74 (40.5%) to 
Environmental Factors categories. A total of 70 second-level categories reflected 
concepts measured in at least 5% of all studies.  
The most commonly found second-level categories of the Body Functions component 
were b160 Thought functions, b156 Perceptual functions, b164 Higher-level cognitive 
functions, b152 Emotional functions, b147 Psychomotor functions, b130 Energy and 
drive functions, b126 Temperament and personality functions, b140 Attention functions 
and b765 Involuntary movement functions (Table 4). Body Structures categories were 
less frequent, and only s110 Structure of brain and s320 Structure of mouth were found 
in at least 5% of all studies (Table 5). With respect to the Activities and Participation 
component, the most often found categories were d720 Complex interpersonal 
interactions, d710 Basic interpersonal interactions, d160 Focusing attention, and d163 
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Thinking (Table 6). Finally, e110 Products or substances for personal consumption was 
the most often found category in the Environmental Factors component (Table 7). 
Insert Tables 3, 4, 5, 6 and 7 about here 
Discussion 
The present study has allowed us to identify and quantify issues commonly addressed in 
published studies focusing on functioning and disability in persons suffering from 
schizophrenia. More specifically, having extracted and linked all the concepts 
underlying the outcomes reported in a representative sample of 206 studies, we are able 
to offer a comprehensive and systematic overview of the concepts included in 
schizophrenia research. In contrast to some other systematic reviews that have been 
centred on randomized controlled trials or on standardized health status instruments (i.e.  
[30,31]), the present review considered other types of designs, such as observational 
studies, as well as studies that administered non-standardized instruments.   
In the framework of the ICF, other systematic reviews have focused on mental health 
disorders, namely depression [32, 33], schizophrenia [34] and bipolar disorder [22]. The 
first of these reviews only included randomized controlled trials, while the latter also 
included observational studies. The percentage of single target diagnosis in the 
systematic review of bipolar disorder was 47% (40% type I and 7% type II bipolar 
disorder), while the corresponding figures in reviews of depressive disorder were 90% 
(87% major depression and 3% dysthymic disorder) [32] and 93% (83% major 
depression, 3% minor depression and 7% depressive episode) [33]. In the present study 
the percentage of single diagnosis was 96% (66% schizophrenia and 30% other 
schizophrenia spectrum disorders).  
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Most of the reviewed studies used standardized measurement tools for the assessment of 
functioning. The three most commonly used standardized tools were the PANSS [27], 
which typically assesses severity of positive and negative symptomatology, the WAIS 
[28], which assesses a wide variety of cognitive functions such as verbal comprehension 
or processing speed, and the WCST [29]), which assesses executive functions. This is a 
noteworthy finding given that the most relevant concepts extracted from the literature 
on schizophrenia are those referring to the Body Functions component, some of which 
are covered by these three assessment instruments. However, for several categories 
identified by the literature review, there are no generic or condition-specific assessment 
instruments in schizophrenia. Moreover, although a range of instruments are currently 
available for assessing the functioning of persons with schizophrenia, none of them 
seems able to provide a comprehensive assessment or offer the degree of specificity 
required for an optimal assessment of this kind [35, 36]. Thus, the development of 
future tools could benefit from the identification of a standardized set of commonly 
affected domains of functioning and disability in schizophrenia. We consider that it is 
possible to adopt a defined list of ICF categories in order to better describe the 
psychopathology and disabilities associated with schizophrenia. A first step in this 
regard would involve developing an ICF-CS for schizophrenia, taking into account four 
complementary perspectives, those of clinicians, researchers, patients and caregivers, 
and experts. This systematic review shows, from the research perspective, which ICF 
categories are important regarding the functioning of patients with schizophrenia. As 
such, the present study constitutes a step forward in the development of an ICF-CS for 
schizophrenia because it helps to identify the ICF categories that, from the perspective 
of researchers, would be most relevant to include. This ICF-CS would provide a 
platform from which to create specific instruments that could offer a more detailed 
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description of these patients’ functioning and which would help to better assess the 
impact of schizophrenia on their HRQOL. Previous studies have demonstrated the 
usefulness of the ICF categories for the comparison and in-depth analysis of generic and 
condition-specific HRQOL instruments [26, 37, 38, 39], as well as for operationalizing 
HRQOL based on the ICF concept of functioning, which integrates health and health-
related aspects [7]. We believe that the biopsychosocial model of the ICF framework 
provides an excellent platform from which to design and carry out studies on HRQOL 
in patients with schizophrenia, in line with what has already been done for other health 
conditions [40]. 
It should be pointed out that a large percentage of concepts could be linked to the ICF 
(85%); this proportion is similar to the one encountered in the systematic review of 
depression (89%) and higher than in the case of bipolar disorder (73%). However, some 
concepts were not linkable to the ICF system. In some cases, the information provided 
in a concept was not sufficient for making a decision about an ICF category, such as 
“level of functioning” or “side effects”. Other concepts referred to a personal factor 
such as “age at onset” or “premorbid IQ”, factors that seem to be related to the course of 
the illness [41] and, thus, to the functioning and disability of patients with 
schizophrenia. Another small proportion of concepts were linked to health conditions, 
for example, schizophrenia, depression, head trauma, neurological disorder and 
substance use disorder. These concepts came from the inclusion and exclusion criteria 
specified in the corresponding studies. Finally, and as was also found in  the systematic 
review of bipolar disorder research [22], in a few cases the coders felt that additional 
codes not currently included in the classification system would be needed to capture 
fully the experience of living with schizophrenia; examples here would be “illness 
duration” or “suicide”. More intense debate is needed in order to decide whether or not 
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such specifications should be included, especially in relation to mental health disorders, 
where these types of features are probably more prominent [42]. 
The high number of second-level ICF categories (n = 202) found in this systematic 
review illustrates the different kinds of difficulties in functioning and disability that are 
faced by patients with schizophrenia. However, it should be pointed out that only 70 
categories appeared in at least 5% of the studies. Most of them (n = 34, 48.6%) refer to 
the Activities and Participation component and are related to the quality of life of the 
patients. A wide variety of domains included in this component (d1 Learning and 
applying knowledge, d5 Self-care, d7 Interpersonal interactions and relationships and 
d8 Major life areas) have frequently been identified as relevant areas of study in this 
population. This finding is consistent with the fact that the major areas of everyday 
functioning that prove problematic for patients with schizophrenia are related to 
interacting with people in a contextually and socially appropriate manner, employment, 
leisure and self-care [41, 43, 44, 45, 46]. According to the literature a significant 
proportion of persons with schizophrenia are unable to fulfil basic social roles, to carry 
out any kind of job or to study [41, 45]. In addition, fewer than 30% of persons with 
schizophrenia work regularly and most of them are underemployed when compared 
with their premorbid employment level [44]. Moreover, one in five persons with 
schizophrenia has a problem with self -care (e.g. washing themselves) and performing 
household duties (e.g. keeping their home tidy) [45]. 
Specifically, our results showed that second-level ICF categories such as d845 
Acquiring, keeping and terminating a job, d920 Recreation and leisure, d510 Washing 
oneself and d570 Looking after one’s health were some of the frequent categories 
highlighted by the research literature for this component, with d720 Complex 
interpersonal interactions and d710 Basic interpersonal interactions being the categories 
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that appeared most often. It should also be noted that two ICF categories, namely d160 
Focusing attention and d163 Thinking, showed a high percentage in chapter d1 
Learning and applying knowledge. This finding supports the idea that cognition plays 
an important role in everyday functioning, such as in activity limitation and 
participation restriction, as numerous studies have pointed out [5, 47, 48, 49, 50].  
The b1 Mental functions chapter is the most frequent area in the Body Functions 
component. Several of the most frequently mentioned mental functions (e.g. b130 
Energy and drive functions, b152 Emotional functions, b156 Perceptual functions and 
b160 Thought functions) are closely related to the most common symptoms of 
schizophrenia, such as negative symptoms, delusions and hallucinations [51]. The 
relevance of other frequently identified categories related to neurocognitive functions 
(e.g. b140 Attention functions and b164 Higher-level cognitive functions) is supported 
by several studies showing that cognitive deficits are core features of schizophrenia [52, 
53, 54, 55]. Another frequent category identified in this component, and related to the 
b7 Neuromusculoskeletal and movement-related functions chapter, is b765 Involuntary 
movement functions, indicating that drug side effects remains an important issue in the 
literature [56, 57]. 
These results for the Body Functions component are clearly consistent with the finding 
that the most frequent body structure identified was s110 Structure of brain. Several 
studies highlight that patients with schizophrenia present subtle but consistent 
differences in certain brain structures and different patterns of brain activity in 
comparison with healthy controls [58, 59, 60, 61]. Moreover, these differences have 
been linked to the neurocognitive and social cognitive deficits associated with 
schizophrenia [62, 63]. 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Regarding environmental factors, the only category to appear with a high frequency 
(85% of the articles) was e110 Products or substances for personal consumption, mostly 
because of the inclusion of the third-level category e1101 Drugs. This percentage of 
appearance is consistent with the fact that there are several issues related to 
pharmacological therapy in this population. Among these, an unsatisfactory response to 
antipsychotic therapy and medication non-adherence are common problems in these 
patients, and they are strongly associated with symptom relapse [64, 65]. Moreover, the 
management of side effects continues to be an important unresolved issue and is a 
common reason for polypharmacy in these patients. It should also be noted that the 
combination of two or more antipsychotics is also frequently observed (10-50%) in 
clinical practice [66, 67, 68]. In addition, it is worth pointing out that the category e110 
Products or substances for personal consumption is also related to substance abuse, 
which is reported as a comorbid condition in at least 47% of patients with schizophrenia 
[69].  
This study does have certain limitations that need to be considered when interpreting 
our results. First, we focused solely on articles published in English. Although this 
choice was made for practical reasons, it may have led us to exclude some in teresting 
studies published in other languages. A further potential limitation is that due to the 
overwhelming number of published studies in this area, we followed the procedure used 
in previous ICF systematic reviews (e.g. [21]) and drew a random sample from among 
the initially retrieved and eligible studies. This procedure has recently been 
recommended by Selb et al. [11].   
In conclusion, this systematic review highlights the research focus of the literature on 
schizophrenia. One contribution of the study is that the ICF categories it identifies 
reveal those aspects of HRQOL, based on the ICF concept of functioning, that are most 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
relevant from the point of view of researchers. Specifically, the results show that most 
of the studies concentrate on the components Body Functions and Activities and 
Participation, rather than on Body Structures and Environmental Factors. In addition, 
this study enables the research perspective to be assimilated into the process of 
developing the ICF-CS for schizophrenia, thus providing a complement to the 
perspectives of patients and caregivers, health professionals and experts in 
schizophrenia. The availability of an ICF-CS for schizophrenia provides a practical tool 
that covers the entire spectrum of functioning of persons with schizophrenia and which 
uses a common language, and as such it can be used in documenting, reporting and 
assessing functioning in schizophrenia in any setting worldwide. Finally, our study also 
shows that the ICF provides a valuable reference for identifying and quantifying the 
concepts underlying the outcomes included in published studies focusing on individuals 
with schizophrenia. 
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Table 1. Examples of the linking process 
Text in the article Meaningful Concepts Linking to ICF Category 
“make emergency calls” - Using telephone - d360 Using communication devices and 
techniques 
“initiate and maintain a 
conversation for 3 min” 
- Initiate a conversation 
- Maintain a conversation 
- d3500 Starting a conversation 
- d3501 Sustaining a conversation 
“She had poor social interaction, 
remained withdrawn and did not 
engage in any household 
activities” 
- Poor social interaction 
- Withdrawn 
- Household activities 
- d710 Basic interpersonal interactions 
- b152 Emotional functions 
- d640 Doing housework  
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Table 2. Frequencies for study characteristics (N = 206) 
 
Number of studies % (95% CI) 
Study type  
   Observational 
          Cross-sectional 
          Longitudinal 
   Intervention 
          RCT 
          CCT 
          Other intervention 


















   <10 
   10-50 
   51-100 










   Schizophrenia alone 
   Schizophrenia spectrum disorders  
   Concomitant pathologies 
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   DSM 
   ICD  
   DSM + ICD 
   Research Diagnostic Criteria 












   Outpatient  
   Inpatient  
   Mixed 









Note: RCT = randomized clinical trial; CCT = controlled clinical trial; DSM = Diagnostic and Statistical 
Manual of Mental Disorders; ICD = International Classification of Diseases   
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Table 3. Frequencies for first-level ICF categories linked to the concepts contained in 
the outcomes of studies (N=206) 
ICF chapters Description Number 
of 
studies 
% (95% CI) 
Body Functions 
  b1 
  b2 
  b3 
  b4 
   
  b5 
  
  b6 
  b7 
 
Mental functions 
Sensory functions and pain 
Voice and speech functions 
Functions of the cardiovascular, haematological, 
immunological and respiratory systems 
Functions of the digestive, metabolic and endocrine 
systems 
Genitourinary and reproductive functions 
























   
  s1 
  s3 
 
Structures of the nervous system 







Activities and Participation 
  d1 
  d2 
  d3 
  d4 
  d5 
  d6 
  d7 
  d8 
  d9 
Learning and applying knowledge 





Interpersonal interactions and relationships 
Major life areas 
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Environmental Factors 
  e1 
  e3 






Products and technology 
Support and relationships 






















Abbreviations: CI, Confidence interval. 
Note: Only categories measured in >5% of all studies are displayed 
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Table 4. Frequencies for second-level ICF categories linked to the concepts contained in 
the outcomes of studies (N=206): Body Functions component 
ICF code Description Number of 
studies 
% (95% CI) 
Chapter 1: Mental functions 
  b110 
  b114 
  b117 
  b122 
  b126 
  b130 
  b134 
  b140 
  b144 
  b147 
  b152 
  b156 
  b160 
  b164 
  b167 
  b172 





Global psychosocial functions 
Temperament and personality functions 








Higher-level cognitive functions 
Mental functions of language 
Calculation functions 




































Chapter 2: Sensory functions and pain 
  b230 







Chapter 3: Voice and speech functions 
  b330 
 
Fluency and rhythm of speech functions 59 28.6 (22.5-34.8) 
Chapter 4: Functions of the cardiovascular, haematological, immunological and respiratory systems 
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  b420 
   






Chapter 5: Functions of the digestive, metabolic and endocrine systems 
  b510 
  b530 
  b555 
Ingestion functions 
Weight maintenance functions 








Chapter 6: Genitourinary and reproductive functions 
  b640 







Chapter 7: Neuromusculoskeletal and movement-related functions 
  b710 
  b730 
  b735 
  b760 
  b765 
  b770 
 
Mobility of joint functions 
Muscle power functions 
Muscle tone functions 
Control of voluntary movement functions 
Involuntary movement functions 













Abbreviations: CI, Confidence interval. 
Note: Only categories measured in >5% of all studies are displayed 
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Table 5. Frequencies for second-level ICF categories linked to the concepts contained in 
the outcomes of studies (N=206): Body Structures component 
ICF code Description Number of 
studies 
% (95% CI) 
Chapter 1: Structures of the nervous system 
  s110 
  s320 
   
Structure of brain 








Abbreviations: CI, Confidence interval. 
Note: Only categories measured in >5% of all studies are displayed 
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Table 6. Frequencies for second-level ICF categories linked to the concepts contained in 
the outcomes of studies (N=206): Activities and Participation component 
ICF code Description Number of 
studies 
% (95% CI) 
Chapter 1: Learning and applying knowledge 
  d135 
  d160 
  d163 
  d166 
  d175 
  d177 






















Chapter 2: General tasks and demands 
  d230 
  d240 
   
 
Carrying out daily routine 









Chapter 3: Communication 
  d315 
 
  d330 
  d335 
  d340 
  d350 
   
Communicating with - receiving - 
nonverbal messages 
Speaking 
Producing nonverbal messages 


















Chapter 4: Mobility 
  d410 
   






Chapter 5: Self-care 
  d510 Washing oneself 65 31.6 (25.2-37.9) 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
  d520 
  d540 
  d550 
  d570 
   
Caring for body parts 
Dressing 
Eating 











Chapter 6: Domestic life 
  d620 
  d630 
  d640 
 









Chapter 7: Interpersonal interactions and relationships 
  d710 
  d720 
  d750 
  d760 
  d770 
 
Basic interpersonal interactions 
Complex interpersonal interactions 













Chapter 8: Major life areas 
  d820 
  d840 
  d845 
  d850 
  d855 
   
School education 
Apprenticeship (work preparation) 
















Chapter 9: Community, social and civic life  
  d910 
  d920 
   
Community life 







Abbreviations: CI, Confidence interval. 
Note : Only categories measured in >5% of all studies are displayed 
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Table 7. Frequencies for second-level ICF categories linked to the concepts contained in 
the outcomes of studies (N=206): Environmental Factors component 
ICF code Description Number of 
studies 
% (95% CI) 
Chapter 1: Products and technology 
  e110 
   
  e115   
     
Products or substances for personal 
consumption 











Chapter 3: Support and relationships 
  e310 







Chapter 5: Services, systems and policies 
  e580 
 
Health services, systems and policies 50 24.3 (18.4-30.1) 
Abbreviations: CI, Confidence interval. 
Note: Only categories measured in >5% of all studies are displayed 
 
  
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
 







This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
APPENDIX: Studies included in the review 
Abbott, C., Juarez, M., White, T., Gollub, R. L., Pearlson, G. D., Bustillo, J., … Calhoun, 
V. D. (2011). Antipsychotic dose and diminished neural modulation: a multi-site 
fMRI study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 
473-482. doi:  10.1016/j.pnpbp.2010.12.001  
Abe,T., Moriya, M., Ikeda, K., Kuroda, K., & Hagihara, A. (2012). Psychiatrist 
characteristics related to patient outcome in Japan. Psychiatric Quarterly, 83, 221-
239. doi: 10.1007/s11126-011-9195-x  
Adcock, R. A., Dale, C., Fisher, M., Aldebot, S., Genevsky, A., Simpson, G. V., 
Nagarajan, S., & Vinogradov, S. (2009). When top-down meets bottom-up: 
auditory training enhances verbal memory in schizophrenia. Schizophrenia 
Bulletin, 35, 1132-1141. doi: 10.1093/schbul/sbp068  
Alvarado, R., Minoletti, A., Torres González, F., Moreno Küstner, B., Madariaga, C., & 
Sepúlveda, R. (2012). Development of community care for people with 
schizophrenia in Chile. International Journal of Mental Health, 41, 48-61.  
Angelopoulos, E., Koutsoukos, E., Maillis, A., Papadimitriou, G. N., & Stefanis, C. 
(2011). Cortical interactions during the experience of auditory verbal 
hallucinations. The Journal of Neuropsychiatry and Clinical Neurosciences, 23, 
287-293. doi: 10.1176/appi.neuropsych.23.3.287  
Ascher-Svanum, H., Zhu, B., Faries, D., Peng, X., Kinon, B. J., & Tohen, M. (2008). 
Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, 
prospective, naturalistic study. The Journal of Clinical Psychiatry, 69, 1580-1588. 
Avery, R., Startup, M., & Calabria, K. (2009). The role of effort, cognitive expectancy 
appraisals and coping style in the maintenance of the negative symptoms of 
schizophrenia. Psychiatry Research, 167, 36-46. doi: 
10.1016/j.psychres.2008.04.016  
Bányai, M., Diwadkar, V. A., & Érdi, P. (2011). Model-based dynamical analysis of 
functional disconnection in schizophrenia. NeuroImage, 58, 870-877. doi: 
10.1016/j.neuroimage.2011.06.046  
Baandrup, L., Sorensen, J., Lublin, H., Nordentoft, M., & Glenthoj, B. (2012). 
Association of antipsychotic polypharmacy with health service cost: a register-
based cost analysis. The European Journal of Health Economics, 13, 353-365. doi: 
10.1007/s10198-011-0308-0  
Baandrup, L., Fagerlund, B., Jennum, P., Lublin, H., Hansen, J. L., Winkel, P., … 
Glenthoj, B. Y. (2011). Prolonged-release melatonin versus placebo for 
benzodiazepine discontinuation in patients with schizophrenia: A randomized 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
clinical trial – the SMART trial protocol. BMC Psychiatry, 11-160. doi: 
10.1186/1471-244x-11-160  
Bahorik, A. L., & Eack, S. M. (2010). Examining the course and outcome of individuals 
diagnosed with schizophrenia and comorbid borderline personality disorder. 
Schizophrenia Research, 124, 29-35. doi: 10.1016/j.schres.2010.09.005  
Bailey, L. J., & Sheehy, R. J. (2009). The state of residential care for people with mental 
illness; insights from an audit of the screening tool for entry to licensed residential 
facilities. Australian & New Zealand Journal of Public Health, 33(2), 140-143. doi: 
10.1111/j.1753-6405.2009.00360.x  
Balaji, M., Chatterjee, S., Brennan, B., Rangaswamy, T., Thornicroft, G., Patel, V. 
(2012). Outcomes that matter: A qualitative study with persons with schizophrenia 
and their primary caregivers in India. Asian Journal of Psychiatry, 5, 258-265. doi: 
10.1016/j.ajp.2012.06.002  
Balogh, Z., Benedek, G., & Keri, S. (2008). Retinal dysfunctions in schizophrenia. 
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32, 297-300. 
doi: 10.1016/j.pnpbp.2007.08.024 
Bandyopadhyaya, D., Nizamie, S. H., Pradhan, N., & Bandyopadhyaya, A. (2011). 
Spontaneous gamma coherence as a possible trait marker of schizophrenia  – An 
explorative study. Asian Journal of Psychiatry, 4, 172-177. doi: 
10.1016/j.ajp.2011.06.006  
Baslet, G., Termini, L., & Herbener, E. (2009). Deficits in emotional awareness in 
schizophrenia and their relationship with other measures of functioning. Journal of 
Nervous & Mental Disease, 197, 655-660. doi: 10.1097/nmd.0b013e3181b3b20f  
Behere, R. V., Arasappa, R., Jagannathan, A., Varambally, S., Venkatasubramanian, G., 
… Gangadhar, B. N. (2011). Effect of yoga therapy on facial emotion recognition 
deficits, symptoms and functioning in patients with schizophrenia . Acta 
Psychiatrica Scandinavica, 123, 147-153. doi: 10.1111/j.1600-0447.2010.01605.x  
Berberian, A. A., Trevisan, B. T., Moriyama, T. S., Montiel, J. M., Oliveira, J. C., & 
Seabra, A. G. (2009). Working memory assessment in schizophrenia and its 
correlation with executive functions ability. Revista Brasileira de Psiquiatria, 31, 
219-226. 
Bertisch, H. C., Fava, J., Kattan, A., & DeLisi, L. E. (2008). Preliminary 
neuropsychological findings in individuals at high genetic risk for schizophrenia. 
Early Intervention in Psychiatry, 2, 45-49. doi: 10.1111/j.1751-7893.2007.00058.x  
Bespalova, I. N., Durner, M., Ritter, B. P., Angelo, G. W., Rossy-Fullana, E., Carrion-
Baralt, J., … Silverman, J. M. (2010). Non-synonymous variants in the AMACR 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
gene are associated with schizophrenia. Schizophrenia Research, 124, 208-215. doi: 
10.1016/j.schres.2010.08.040  
Blasi, G., Taurisano, P., Papazacharias, A., Caforio, G., Romano, R., … Bertolino, A. 
(2010). Nonlinear response of the anterior cingulate and prefrontal cortex in 
schizophrenia as a function of variable attentional control. Cerebral Cortex, 20, 
837-845. doi: 10.1093/cercor/bhp146  
Blasi, G., Napolitano, F., Ursini, G., Taurisano, P., Romano, R., … Bertolino, A. (2011). 
DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional 
processing, and response to olanzapine treatment in schizophrenia. Proceedings of 
the National Academy of Sciences of the United States of America, 108, 1158-1163. 
doi: 10.1073/pnas.1013535108  
Bonner-Jackson, A., Yodkovik, N., Csernansky, J. G., & Barch, D. M. (2008). Episodic 
memory in schizophrenia: the influence of strategy use on behavior and brain 
activation. Psychiatry Research, 164, 1-15. doi: 
10.1016/j.pscychresns.2007.12.012  
Boot, E., Booij, J., Abeling, N., Meijer, J., da Silva,  A., … van Amelsvoort, T. (2011). 
Dopamine metabolism in adults with 22q11 deletion syndrome, with and without 
schizophrenia - relationship with COMT Val108/158Met polymorphism, gender and 
symptomatology. Journal of Psychopharmacology, 25, 888-895. doi: 
10.1177/0269881111400644  
Bowie, C. R., & Harvey, P. D. (2008). Communication abnormalities predict functional 
outcomes in chronic schizophrenia: differential associations with social and 
adaptive functions. Schizophrenia Research, 103, 240-247. doi: 
10.1016/j.schres.2008.05.006  
Bowie, C. R., Reichenberg, A., McClure, M. M., Leung, W. L., & Harvey, P. D. (2008). 
Age-associated differences in cognitive performance in older community dwelling 
schizophrenia patients: differential sensitivity of clinical neuropsychological and 
experimental information processing tests. Schizophrenia Research, 106, 50-58. 
Bozikas, V. P., Kosmidis, M. H., Peltekis, A., Giannakou, M., Nimatoudis, I., … 
Garyfallos, G. (2010). Sex differences in neuropsychological functioning among 
schizophrenia patients. Australian and New Zealand Journal of Psychiatry, 44, 333-
341. doi: 10.3109/00048670903489833  
Bradley, E., Lunsky, Y., Palucka, A., & Homitidis, S. (2011). Recognition of intellectual 
disabilities and autism in psychiatric inpatients diagnosed with schizophrenia and 
other psychotic disorders. Advances in Mental Health and Intellectual Disabilities, 
5, 4-18. doi: 10.1108/20441281111187153  
Buchanan, R. W., Keefe, R. S., Lieberman, J. A., Barch, D. M., Csernansky, J. G., … 
Marder, S. R. (2011). A randomized clinical trial of MK-0777 for the treatment of 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
cognitive impairments in people with schizophrenia. Biological Psychiatry, 69, 
442-449. doi: 10.1016/j.biopsych.2010.09.052  
Byerly, M. J., Nakonezny, P. A., & Rush, A. J. (2008). Sexual functioning associated 
with quetiapine switch vs. risperidone continuation in outpatients with 
schizophrenia or schizoaffective disorder: A randomized double-blind pilot trial. 
Psychiatry Research, 159, 115-120. doi: 10.1016/j.psychres.2007.02.014  
Calhoun, V. D., Maciejewski, P. K., Pearlson, G. D., & Kiehl, K. A. (2008). Temporal 
lobe and "default" hemodynamic brain modes discriminate between schizophrenia 
and bipolar disorder. Human Brain Mapping, 29, 1265-1275. 
Calkins, M. E., Tepper, P., Gur, R. C., Ragland, J. D., Klei, L., … Gur, R. E. (2010). 
Project among African-Americans to explore risks for schizophrenia 
(PAARTNERS): evidence for impairment and heritability of neurocognitive 
functioning in families of schizophrenia patients. American Journal of Psychiatry, 
167, 459-472. doi: 10.1176/appi.ajp.2009.08091351  
Candilis, P. J., Fletcher, K. E., Geppert, C. M. A., Lidz, C. W., & Appelbaum, P. S. 
(2008). A direct comparison of research decision-making capacity: 
Schizophrenia/schizoaffective, medically ill, and non-ill subjects. Schizophrenia 
Research, 99, 350-358. doi: 10.1016/j.schres.2007.11.022  
Canuso, C. M., Bossie, C. A., Turkoz, I., & Alphs, L. (2009). Paliperidone extended-
release for schizophrenia: Effects on symptoms and functioning in acutely ill 
patients with negative symptoms. Schizophrenia Research, 113, 56-64. doi: 
10.1016/j.schres.2009.05.021  
Cavelti, M., Kvrgic, S., Beck, E.-M.; Rüsch, N., & Vauth, R. (2012). Self-stigma and its 
relationship with insight, demoralization, and clinical outcome among people with 
schizophrenia spectrum disorders. Comprehensive Psychiatry, 53, 468-479. doi: 
10.1016/j.comppsych.2011.08.001  
Champagne-Lavau, M., & Stip, E. (2010). Pragmatic and executive dysfunction in 
schizophrenia. Journal of Neurolinguistics, 3, 285-296. doi: 
10.1016/j.jneuroling.2009.08.009  
Chan, R. C., Huang, J., Guo, L., Cao, X., Hong, X., & Gao, Z. (2010). Executive control 
in schizophrenia in task involving semantic inhibition and working memory. 
Psychiatry Research, 179, 259-266. doi: 10.1016/j.psychres.2009.07.014  
Chen, J., Calhoun, V. D., Pearlson, G. D., Ehrlich, S., Turner, J. A., … Liu, J. (2012). 
Multifaceted genomic risk for brain function in schizophrenia. NeuroImage, 61, 
866-875. doi: 10.1016/j.neuroimage.2012.03.022 
Chen, Y., Grossman, E. D., Bidwell, L. C., Yurgelun-Todd, D., Gruber, S. A., … 
Holzman, P. S. (2008). Differential activation patterns of occipital and prefrontal 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
cortices during motion processing: evidence from normal and schizophrenic brains. 
Cognitive, Affective & Behavioral Neuroscience, 8, 293-303. 
Cheng, S. T., Yip, L. C., Jim, O. T., & Hui, A. N. (2012). Self-perception of aging and 
acute medical events in chronically institutionalized middle-aged and older persons 
with schizophrenia. International Journal of Geriatric Psychiatry, 27, 907-913. 
doi: 10.1002/gps.2798  
Cohen, A. S., Nienow, T. M., Dinzeo, T. J., & Docherty, N. M. (2009). Attribution biases 
in schizophrenia: relationship to clinical and functional impairments. 
Psychopathology, 42, 40-46. doi: 10.1159/000173702 
Corradi-Dell'Acqua, C., Tomelleri, L., Bellani, M., Rambaldelli, G., Cerini, R., … 
Brambilla, P. (2012). Thalamic-insular dysconnectivity in schizophrenia: Evidence 
from structural equation modeling. Human Brain Mapping, 33, 740-752. doi: 
10.1002/hbm.21246 
Couture, S. M., Penn, D. L., Addington, J., Woods, S. W. & Perkins, D. O. (2008). 
Assessment of social judgments and complex mental states in the early phases of 
psychosis. Schizophrenia Research, 100, 237-241. doi: 
10.1016/j.schres.2007.12.484 
Crowley, V., Rose, J., Smith, J., Hobster, K. & Ansell, E. (2008). Psycho-educational 
groups for people with a dual diagnosis of psychosis and mild intellectual disability: 
A preliminary study. Journal of Intellectual Disabilities, 12, 25-39. doi: 
10.1177/1744629507086606 
de Jong, J. J., Hodiamont, P. P., Van den Stock, J. & de Gelder, B. (2009). Audiovisual 
emotion recognition in schizophrenia: Reduced integration of facial and vocal 
affect. Schizophrenia Research, 107, 286-293. doi: 10.1016/j.schres.2008.10.001 
Demirci, O., Stevens, M. C., Andreasen, N. C., Michael, A., Liu, J., … Calhoun, V. D. 
(2009). Investigation of relationships between fMRI brain networks in the spectral 
domain using ICA and Granger causality reveals distinct differences between 
schizophrenia patients and healthy controls. NeuroImage, 46, 419-431. doi: 
10.1016/j.neuroimage.2009.02.014 
Di Giorgio, A., Caforio, G., Blasi, G., Taurisano, P., Fazio, L., … Bertolino, A. (2011). 
Catechol-O-methyltransferase Val(158)Met association with parahippocampal 
physiology during memory encoding in schizophrenia. Psychological Medicine, 41, 
1721-1731. doi: 10.1017/S0033291710002278 
Diaz-Asper, C. M., Goldberg, T. E., Kolachana, B. S., Straub, R. E., Egan, M. F. & 
Weinberger, D. R. (2008). Genetic variation in catechol-O-methyltransferase: 
effects on working memory in schizophrenic patients, their siblings, and healthy 
controls. Biological Psychiatry, 63, 72-79. doi: 10.1016/j.biopsych.2007.03.031 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Dima, D., Dillo, W., Bonnemann, C., Emrich, H. M. & Dietrich, D. E. (2011). Reduced 
P300 and P600 amplitude in the hollow-mask illusion in patients with 
schizophrenia. Psychiatry Research, 191, 145-151. doi: 
10.1016/j.pscychresns.2010.09.015 
Edlinger, M., Deisenhammer, E. A., Fiala, M., Hofer, A., Kemmler, G., … Fleischhacker, 
W. W. (2010). Attitudes of patients with schizophrenia and depression towards 
psychiatric research. Psychiatry Research, 177, 172-176. doi: 
10.1016/j.psychres.2008.12.010 
Egan, G. J., Hasenkamp, W., Wilcox, L., Green, A., Hsu, N. … Duncan, E. (2011). 
Declarative memory and WCST-64 performance in subjects with schizophrenia and 
healthy controls. Psychiatry Research, 188, 191-196. doi: 
10.1016/j.psychres.2011.02.026 
Faget-Agius, C., Boyer, L., Padovani, R., Richieri, R., Mundler, O., … Guedj, E. (2012). 
Schizophrenia with preserved insight is associated with increased perfusion of the 
precuneus. Journal of Psychiatry & Neuroscience: JPN, 37, 297-304. doi: 
10.1503/jpn.110125 
Falkenberg, I., Bartels, M., & Wild, B. (2008). Keep smiling! Facial reactions to 
emotional stimuli and their relationship to emotional contagion in patients with 
schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 258, 
245-253. doi: 10.1007/s00406-007-0792-5 
Fallgatter, A. J., Ehlis, A. C., Herrmann, M. J., Hohoff, C., Reif, A., … Deckert, J. (2010). 
DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in 
schizophrenic patients--support for the glutamate hypothesis of schizophrenias. 
Genes, Brain, and Behavior, 9, 489-497. doi: 10.1111/j.1601-183X.2010.00574.x 
Feifel, D., Macdonald, K., Cobb, P., & Minassian, A. (2012). Adjunctive intranasal 
oxytocin improves verbal memory in people with schizophrenia. Schizophrenia 
Research, 139, 207-210. doi: 10.1016/j.schres.2012.05.018 
Fischer, E. P., McCarthy, J. F., Ignacio, R. V., Blow, F. C., Barry, K. L., … Valenstein, 
M. (2008). Longitudinal patterns of health system retention among veterans with 
schizophrenia or bipolar disorder. Community Mental Health Journal, 44, 321-330. 
doi: 10.1007/s10597-008-9133-z 
Fisher, M., McCoy, K., Poole, J. H., & Vinogradov, S. (2008). Self and other in 
schizophrenia: a cognitive neuroscience perspective. American Journal of 
Psychiatry, 165, 1465-1472. doi: 10.1176/appi.ajp.2008.07111806 
Foti, D., Kotov, R., Bromet, E., & Hajcak, G. (2012). Beyond the broken error-related 
negativity: functional and diagnostic correlates of error processing in psychosis. 
Biological Psychiatry, 71, 864-872. doi: 10.1016/j.biopsych.2012.01.007 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Fujiwara, H., Shimizu, M., Hirao, K., Miyata, J., Namiki, C., … Murai, T. (2008). Female 
specific anterior cingulate abnormality and its association with empathic disability 
in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 
32, 1728-1734. doi: 10.1016/j.pnpbp.2008.07.013 
Galletly, C., Neaves, A., Burton, C., Liu, D., & Denson, L. A. (2012). Evaluating health 
literacy in people with mental illness using the Test of functional Health Literacy 
in Adults. Nursing Outlook, 60, 316-321. doi: 10.1016/j.outlook.2012.01.003 
Garlinghouse, M. A., Roth, R. M., Isquith, P. K., Flashman, L. A., & Saykin, A. J. (2010). 
Subjective rating of working memory is associated with frontal lobe volume in 
schizophrenia. Schizophrenia Research, 120, 71-75. doi: 
10.1016/j.schres.2010.02.1067 
Gold, R., Butler, P., Revheim, N., Leitman, D. I., Hansen, J. A., … Javitt, D. C. (2012). 
Auditory emotion recognition impairments in schizophrenia: relationship to  
acoustic features and cognition. American Journal of Psychiatry, 169, 424-432. doi: 
10.1176/appi.ajp.2011 
Goldberg, R. W., Hackman, A., Medoff, D. R., Brown, C., Fang, L. J., … Dixon, L. 
(2008). Physical wellness and employment status among adults with serious mental 
illness. Community Mental Health Journal, 44, 245-251. doi: 10.1007/s10597-008-
9124-0 
Grant, P. M., & Beck, A. T. (2009). Evaluation sensitivity as a moderator of 
communication disorder in schizophrenia. Psychological Medicine, 39, 1211-1219. 
doi: 10.1017/S0033291709005479 
Grant, P. M. & Beck, A. T. (2009). Defeatist beliefs as a mediator of cognitive 
impairment, negative symptoms, and functioning in schizophrenia. Schizophrenia 
Bulletin, 35, 798-806. doi: 10.1093/schbul/sbn008 
Greenwood, K. E., Morris, R., Sigmundsson, T., Landau, S., & Wykes, T. (2008). 
Executive functioning in schizophrenia and the relationship with symptom profile 
and chronicity. Journal of the International Neuropsychological Society, 14, 782-
792. doi: 10.1017/S1355617708081198 
Grimm, E. Z., Meus, J. S., Brown, C., Exley, S. M., Hartman, S., … Manner, T. (2009). 
Meal preparation: comparing treatment approaches to increase acquisition of skills 
for adults with schizophrenic disorders. Occupation, Participation and Health, 29, 
148-153. doi: 10.3928/15394492-20090914-02 
Grimm, O., Vollstädt-Klein, S., Krebs, L., Zink, M. & Smolka, M. N. (2012). Reduced 
striatal activation during reward anticipation due to appetite-provoking cues in 
chronic schizophrenia: A fMRI study. Schizophrenia Research, 134, 151-157. doi: 
10.1016/j.schres.2011.11.027 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Grover, S., Chakrabarti, S., Aggarwal, M., Avasthi, A., Kulhara, P., … Khehra, N. (2012). 
Comparative study of the experience of caregiving in bipolar affective disorder and 
schizophrenia. International Journal of Social Psychiatry, 58, 614-622. doi: 
10.1177/0020764011419054 
Grube, S., Gerchen, M. F., Adamcio, B., Pardo, L. A., Martin, S., … Ehrenreich, H. 
(2011). A CAG repeat polymorphism of KCNN3 predicts SK3 channel function 
and cognitive performance in schizophrenia. EMBO Molecular Medicine, 3, 309-
319. doi: 10.1002/emmm.201100135 
Hahn, C., Neuhaus, A. H., Pogun, S., Dettling, M., Kotz, S. A., … Güntürkün, O. (2011). 
Smoking reduces language lateralization: A dichotic listening study with control 
participants and schizophrenia patients. Brain and Cognition, 76, 300-309. doi: 
10.1016/j.bandc.2011.03.015 
Hanlon, R., Coda, J., Cobia, D., & Rubin, L. (2012). Psychotic Domestic Murder: 
Neuropsychological Differences Between Homicidal and Nonhomicidal 
Schizophrenic Men. Journal of Family Violence, 27, 105-113. doi: 
10.1007/s10896-011-9410-4 
Hansen, J. P., Ostergaard, B., Nordentoft, M., & Hounsgaard, L. (2012). Cognitive 
adaptation training combined with assertive community treatment: A randomised 
longitudinal trial. Schizophrenia Research, 135, 105-111. doi: 
10.1016/j.schres.2011.12.014 
Haraldsson, H. M., Ettinger, U., Magnusdottir, B. B., Sigmundsson, T., Sigurdsson, E., 
… Petursson, H. (2010). Catechol-O-methyltransferase Val158Met polymorphism 
and antisaccade eye movements in schizophrenia. Schizophrenia Bulletin, 36, 157-
164. doi: 10.1093/schbul/sbn064 
Hashim, H. M., Fawzy, N., Fawzi, M. M., & Karam, R. A. (2012). Brain-derived 
neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms 
in Egyptian schizophrenia patients. Journal of Psychiatric Research, 46, 762-766. 
doi: 10.1016/j.jpsychires.2012.03.007 
Hashimoto, R., Ohi, K., Yasuda, Y., Fukumoto, M., Iwase, M., … Takeda, M. (2010). 
The impact of a genome-wide supported psychosis variant in the ZNF804A gene 
on memory function in schizophrenia. American Journal of Medical Genetics. Part 
B, 153B, 1459-1464. doi: 10.1002/ajmg.b.31123 
Hassan, G. A., & Taha, G. R. (2011). Long term functioning in early onset psychosis: two 
years prospective follow-up study. Behavioral and Brain Functions, 7-28. doi: 
10.1186/1744-9081-7-28 
Holliday, E. G., McLean, D. E., Nyholt, D. R., & Mowry, B. J. (2009). Susceptibility 
locus on chromosome 1q23-25 for a schizophrenia subtype resembling deficit 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
schizophrenia identified by latent class analysis. Archives of General Psychiatry, 
66, 1058-1067. doi: 10.1001/archgenpsychiatry.2009.136 
Hong, L. E., Thaker, G. K., McMahon, R. P., Summerfelt, A., Rachbeisel, J., … Nye, A. 
(2011). Effects of moderate-dose treatment with varenicline on neurobiological and 
cognitive biomarkers in smokers and nonsmokers with schizophrenia or 
schizoaffective disorder. Archives of General Psychiatry, 68, 1195-1206. doi: 
10.1001/archgenpsychiatry.2011.83 
Hori, H., Yoshimura, R., Katsuki, A., Hayashi, K., Ikenouchi-Sugita, A., … Nakamura, 
J. (2012). Several prescription patterns of antipsychotic drugs influence cognitive 
functions in Japanese chronic schizophrenia patients. International Journal of 
Psychiatry in Clinical Practice, 16, 138-142. doi: 10.3109/13651501.2011.631018 
Horton, H. K. (2010). Linguistic ability and mental health outcomes among deaf people 
with schizophrenia. Journal of Nervous & Mental Disease, 198, 634-642. doi: 
10.1097/NMD.0b013e3181e9dd23 
Horton, H. K., & Silverstein, S. M. (2008). Social cognition as a mediator of cognition 
and outcome among deaf and hearing people with schizophrenia . Schizophrenia 
Research, 105, 125-137. doi: 10.1016/j.schres.2008.07.003 
Hunter, R., & Barry, S. (2012). Negative symptoms and psychosocial functioning in 
schizophrenia: Neglected but important targets for treatment. European Psychiatry, 
27, 432-436. doi: 10.1016/j.eurpsy.2011.02.015 
Ichioka, S., Terao, T., Hoaki, N., Matsushita, T., & Hoaki, T. (2012). Triiodothyronine 
may be possibly associated with better cognitive function and less extrapyramidal 
symptoms in chronic schizophrenia. Progress in Neuro-Psychopharmacology & 
Biological Psychiatry, 39, 170-174. doi: 10.1016/j.pnpbp.2012.06.008 
Ivleva, E. I., Morris, D. W., Osuji, J., Moates, A. F., Carmody, T. J., … Tamminga, C. A. 
(2012). Cognitive endophenotypes of psychosis within dimension and diagnosis. 
Psychiatry Research, 196, 38-44. doi: 10.1016/j.psychres.2011.08.021 
Jahn, T., Pitschel-Walz, G., Gsottschneider, A., Froböse, T., Kraemer, S., & Bäuml, J. 
(2011). Neurocognitive prediction of illness knowledge after psychoeducation in 
schizophrenia: Results from the Munich COGPIP study. Psychological Medicine, 
41, 533-544. doi : 10.1017/S0033291710001029 
Jiménez, J. A., Mancini-Marïe, A., Lakis, N., Rinaldi, M., & Mendrek, A. (2010). 
Disturbed sexual dimorphism of brain activation during mental rotation in 
schizophrenia. Schizophrenia Research, 122, 53-62. doi: 
10.1016/j.schres.2010.03.011 
Johansen, R., Hestad, K., Iversen, V. C., Agartz, I., Sundet, K., … Melle, I. (2011). 
Cognitive and clinical factors are associated with service engagement in early-
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
phase schizophrenia spectrum disorders. Journal of Nervous & Mental Disease, 
199, 176-182. doi: 10.1097/NMD.0b013e31820bc2f9 
Johnson, D. P., Penn, D. L., Bauer, D. J., Meyer, P., & Evans, E. (2008). Predictors of the 
therapeutic alliance in group therapy for individuals with treatment-resistant 
auditory hallucinations. British Journal of Clinical Psychology, 47, 171-184. doi: 
10.1348/014466507X241604 
Johnson, E. I., Grondin, O., Barrault, M., Faytout, M., Helbig, S., … Swendsen, J. (2009). 
Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study 
of acceptability, compliance, and reactivity. International Journal of Methods in 
Psychiatric Research, 18, 48-57. doi: 10.1002/mpr.276 
Jurado-Barba, R., Morales-Munoz, I., Del Manzano, B. A., Fernandez-Guinea, S., 
Caballero, M., … Rubio-Valladolid, G. (2011). Relationship between measures of 
inhibitory processes in patients with schizophrenia: role of substance abuse 
disorders. Psychiatry Research, 190, 187-192. doi: 10.1016/j.psychres.2011.06.002 
Kelly, D. L., McMahon, R. P., Weiner, E., Boggs, D. L., Dickinson, D., … Buchanan, R. 
W. (2008). Lack of beneficial galantamine effect for smoking behavior: A double-
blind randomized trial in people with schizophrenia. Schizophrenia Research, 103, 
161-168. doi: 10.1016/j.schres.2008.04.027 
Keshavan, M. S., Eack, S. M., Wojtalik, J. A., Prasad, K. M., Francis, A. N., … Hogarty, 
S. S. (2011). A broad cortical reserve accelerates response to cognitive 
enhancement therapy in early course schizophrenia. Schizophrenia Research, 130, 
123-129. doi: 10.1016/j.schres.2011.05.001 
Kikuchi, T., Iwamoto, K., Sasada, K., Aleksic, B., Yoshida, K., & Ozaki, N. (2012). 
Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients 
taking antipsychotics. Progress in Neuro-Psychopharmacology & Biological 
Psychiatry, 37, 26-32. doi: 10.1016/j.pnpbp.2011.11.016 
Kim, S. H., Song, J. Y., Joo, E. J., Lee, K. Y., Shin, S. Y., Lee, Y. H., … Kim, Y. S. 
(2012). Genetic association of the EGR2 gene with bipolar disorder in Korea. 
Experimental & Molecular Medicine, 44, 121-129. doi: 
10.3858/emm.2012.44.2.007 
Kim, S. W., Shin, I. S., Kim, J. M., Lee, S. H., Lee, Y. H., … Yoon, J. S. (2009). Effects 
of switching to long-acting injectable risperidone from oral atypical antipsychotics 
on cognitive function in patients with schizophrenia. Human Psychopharmacology, 
24, 565-573. doi: 10.1002/hup.1057 
Kopald, B. E., Mirra, K. M., Egan, M. F., Weinberger, D. R., & Goldberg, T. E. (2012). 
Magnitude of impact of executive functioning and IQ on episodic memory in 
Schizophrenia. Biological Psychiatry, 71, 545-551. doi: 
10.1016/j.biopsych.2011.11.021 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Krakowski, M. I., Czobor, P., & Nolan, K. A. (2008). Atypical antipsychotics, 
neurocognitive deficits, and aggression in schizophrenic patients. Journal of 
Clinical Psychopharmacology, 28, 485-493. doi: 10.1097/JCP.0b013e3181855cd6 
Lévy-Rueff, M., Gourevitch, R., Lôo, H., Olié, J.-P., & Amado, I. (2010). Maintenance 
electroconvulsive therapy: An alternative treatment for refractory schizophrenia  
and schizoaffective disorders. Psychiatry Research, 175, 280-283. doi: 
10.1016/j.psychres.2008.10.012 
Lakis, N., Jimenez, J. A., Mancini-Marie, A., Stip, E., Lavoie, M. E., & Mendrek, A. 
(2011). Neural correlates of emotional recognition memory in schizophrenia: 
effects of valence and arousal. Psychiatry Research, 194, 245-256. doi: 
10.1016/j.pscychresns.2011.05.010 
Laroche, F., Ramoz, N., Leroy, S., Fortin, C., Rousselot-Paillet, B., … Robel, L. (2008). 
Polymorphisms of coding trinucleotide repeats of homeogenes in 
neurodevelopmental psychiatric disorders. Psychiatric Genetics, 18, 295-301. doi: 
10.1097/YPG.0b013e3283060fa5 
Lee, J. S., Chun, J. W., In K. J., Kang, D.-I, Park, H. J., & Kim, J.-J. (2012). Hippocampus 
and nucleus accumbens activity during neutral word recognition related to trait 
physical anhedonia in patients with schizophrenia: An fMRI study . Psychiatry 
Research: Neuroimaging, 203, 46-53. doi: 10.1016/j.pscychresns.2011.09.004 
Leifker, F. R., Bowie, C. R., & Harvey, P. D. (2009). Determinants of everyday outcomes 
in schizophrenia: the influences of cognitive impairment, functional capacity, and 
symptoms. Schizophrenia Research, 115, 82-87. doi: 10.1016/j.schres.2009.09.004 
Lennertz, L., Quednow, B. B., Schuhmacher, A., Petrovsky, N., Frommann, I., … 
Mössner, R. (2012). The functional coding variant Asn107Ile of the neuropeptide 
S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal 
memory and the acoustic startle response. The international Journal of 
Neuropsychopharmacology, 15, 1205-1215. doi: 10.1017/S1461145711001623 
Leonard, C. M., Kuldau, J. M., Maron, L., Ricciuti, N., Mahoney, B., … DeBose, C. 
(2008). Identical neural risk factors predict cognitive deficit in dyslexia and 
schizophrenia. Neuropsychology, 22, 147-158. doi: 10.1037/0894-4105.22.2.147 
Lepage, M., Pelletier, M., Achim, A., Montoya, A., Menear, M., & Lal, S. (2010). Parietal 
cortex and episodic memory retrieval in schizophrenia. Psychiatry Research: 
Neuroimaging, 182, 191-199. doi: 10.1016/j.pscychresns.2010.03.002 
Liberman, R. P., & Kopelowicz, A. (2009). Training skills for illness self-management 
in the rehabilitation of schizophrenia. A family-assisted program for Latinos in 
California. Salud Mental, 32, 93-105.  
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Liu, Y., Liang, M., Zhou, Y., He, Y., Hao, Y., … Jiang, T. (2008). Disrupted small-world 
networks in schizophrenia. Brain, 131, 945-961. doi: 10.1093/brain/awn018 
Lorente-Rovira, E., Santos-Gomez, J. L., Moro, M., Villagran, J. M., & McKenna, P. J. 
(2010). Confabulation in schizophrenia: a neuropsychological study. Journal of the 
International Neuropsychological Society, 16, 1018-1026. doi: 
10.1017/S1355617710000718 
Mössner, R., Schuhmacher, A., Schulze-Rauschenbach, S., Kühn, K.-U., Rujescu, D., & 
Maier, W. (2008). Further evidence for a functional role of the glutamate receptor 
gene GRM3 in schizophrenia. European Neuropsychopharmacology, 18, 768-772. 
doi: 10.1016/j.euroneuro.2008.05.007 
Mühleisen, T. W., Basmanav, F. B., Forstner, A. J., Mattheisen, M. Priebe, L., … Cichon, 
S. (2011). Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia 
patients. Schizophrenia Research, 127, 35-40. doi: 10.1016/j.schres.2011.01.001 
Margetic, B., Aukst-Margetic, B., Ivanec, D., & Filipcic, I. (2008). Perception of 
stigmatization in forensic patients with schizophrenia. International Journal of 
Social Psychiatry, 54, 502-513. doi: 10.1177/0020764008090842 
Markela-Lerenc, J., Schmidt-Kraepelin, C., Roesch-Ely, D., Mundt, C., Weisbrod, M., & 
Kaiser, S. (2009). Stroop interference effect in schizophrenic patients: An 
electrophysiological approach. International Journal of Psychophysiology, 71, 248-
257. doi: 10.1016/j.ijpsycho.2008.10.005 
Maziade, M., Rouleau, N., Mérette, C., Cellard, C., Battaglia, M., … Roy, M.-A. (2011). 
Verbal and visual memory impairments among young offspring and healthy 
relatives of patients with schizophrenia and bipolar disorder: Selective generational 
patterns indicate different developmental trajectories. Schizophrenia Bulletin, 37, 
1218-1228. doi: 10.1093/schbul/sbq026 
McClay, J. L., Adkins, D. E., Aberg, K., Bukszar, J., Khachane, A. N., … van den Oord, 
E. J. C. G. (2011). Genome-wide pharmacogenic study of neurocognition as an 
indicator of antipsychotic treatment response in schizophrenia. 
Neuropsychopharmacology, 36, 616-626. doi: 10.1038/npp.2010.193 
Mencacci, C. on behalf of all investigators. (2012). Efficacy and tolerability of switching 
to ziprasidone in Italian patients with acute exacerbation of schizophrenia: An open-
label trial. Pharmacopsychiatry, 45, 236-240. doi: 10.1055/s-0032-1301884 
Minzenberg, M. J., Yoon, J. H., Soosman, S. K., & Carter, C. S. (2012). Excessive 
contralateral motor overflow in schizophrenia measured by fMRI. Psychiatry 
Research: Neuroimaging, 202, 38-45. doi: 10.1016/j.pscychresns.2012.03.005  
Mobascher, A., Warbrick, T., Brinkmeyer, J., Musso, F., Stoecker, T., … Winterer, G. 
(2012). Nicotine effects on anterior cingulate cortex in schizophrenia and healthy 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
smokers as revealed by EEG-informed fMRI. Psychiatry Research: Neuroimaging, 
204, 168-177. doi: 10.1016/j.pscychresns.2012.09.005 
Moens, L. N., De Rijk, P., Reumers, J., Van den Bossche, M. J., Glassee, W., … Del-
Favero, J. (2011). Sequencing of DISC1 pathway genes reveals increased burden 
of rare missense variants in schizophrenia patients from a northern Swedish 
population. PloS One, 6, e23450. doi: 10.1371/journal.pone.0023450 
Murthy, N. V., Mahncke, H., Wexler, B. E., Maruff, P., Inamdar, A., … Alexander, R. 
(2012). Computerized cognitive remediation training for schizophrenia: An open 
label, multi-site, multinational methodology study. Schizophrenia Research, 139, 
87-91. doi: 10.1016/j.schres.2012.01.042 
Nakagami, E., Hoe, M., & Brekke, J. S. (2010). The prospective relationships among 
intrinsic motivation, neurocognition, and psychosocial functioning in 
schizophrenia. Schizophrenia Bulletin, 36, 935-948. doi: 10.1093/schbul/sbq043 
Naz, M., Riaz, M., & Saleem, M. (2011). Potential role of Neuregulin 1 and TNF-alpha 
(-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, 
Pakistan. Molecular Biology Reports, 38, 4709-4714. doi: 10.1007/s11033-010-
0606-0 
Newman, S. C., Bland, R. C., & Thompson, A. H. (2012). Long-term course and outcome 
in schizophrenia: A 34-year follow-up study in Alberta, Canada. Psychological 
Medicine, 42, 2137-2143. doi: 10.1017/S0033291712000177 
Nieratschker, V., Frank, J., Mühleisen, T. W., Strohmaier, J., Wendland, J. R., … Schulze, 
T. G. (2010). The catechol-O-methyl transferase (COMT) gene and its potential 
association with schizophrenia: Findings from a large German case-control and 
family-based sample. Schizophrenia Research, 122, 24-30. doi: 
10.1016/j.schres.2010.06.018 
Nozawa, M., Ohnuma, T., Matsubara, Y., Sakai, Y., Hatano, T., … Arai, H. (2008). The 
relationship between the response of clinical symptoms and plasma olanzapine 
concentration, based on pharmacogenetics: Juntendo University Schizophrenia 
Projects (JUSP). Therapeutic Drug Monitoring, 30, 35-40. doi: 
10.1097/FTD.0b013e31816336fd 
Oh, S.-Y., & Kim, Y.-K. (2011). Adjunctive treatment of bimodal repetitive transcranial 
magnetic stimulation (rTMS) in pharmacologically non-responsive patients with 
schizophrenia: A preliminary study. Progress in Neuro-Psychopharmacology & 
Biological Psychiatry, 35, 1938-1943. doi: 10.1016/j.pnpbp.2011.07.015 
Ojeda, N., Peña, J., Sánchez, P., Bengoetxea, E., Elizagárate, … Gutiérrez Fraile, M. 
(2012). Efficiency of cognitive rehabilitation with REHACOP in chronic treatment 
resistant Hispanic patients. NeuroRehabilitation, 30, 65-74. doi: 10.3233/NRE-
2011-0728 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Olfson, M., Ascher-Svanum, H., Faries, D. E., & Marcus, S. C. (2011). Predicting 
psychiatric hospital admission among adults with schizophrenia. Psychiatric 
Services, 62, 1138-1145. doi: 10.1176/appi.ps.62.10.1138 
Otnaess, M. K., Djurovic, S., Rimol, L. M., Kulle, B., Kahler, A. K., … Andreassen, O. 
A. (2009). Evidence for a possible association of neurotrophin receptor (NTRK-3) 
gene polymorphisms with hippocampal function and schizophrenia. Neurobiology 
of Disease, 34, 518-524. doi: 10.1016/j.nbd.2009.03.011 
Ozcan, O., Ipcioglu, O. M., Gultepe, M., & Basoglu, C. (2008). Altered red cell 
membrane compositions related to functional vitamin B12 deficiency manifested 
by elevated urine methylmalonic acid concentrations in patients with schizophrenia. 
Annals of Clinical Biochemistry, 45, 44-49. doi: 10.1258/acb.2007.007057 
Parellada, E., Kouniakis, F., Siurkute, A., Schreiner, A., & Don, L. (2010). Safety and 
efficacy of long-acting injectable risperidone in daily practice: An open-label, 
noninterventional, prospective study in schizophrenia and related disorders. 
International Clinical Psychopharmacology, 25, 149-154. doi: 
10.1097/YIC.0b013e328336c93f 
Park, I. H., Park, H. J., Chun, J. W., Kim, E. Y., & Kim, J. J. (2008). Prefrontal functional 
dissociation in the semantic network of patients with schizophrenia. Neuroreport, 
19, 1391-1395. doi: 10.1097/WNR.0b013e32830cebff 
Park, I. H., Kim, J.-J., Ku, J., Jang, H. J., Park, S.-H., … Kim, S. I. (2009). Characteristics 
of social anxiety from virtual interpersonal interactions in patients with 
schizophrenia. Psychiatry, 72, 79-93. doi: 10.1521/psyc.2009.72.1.79 
Park, S., & Kim, K. (2011). Physiological reactivity and facial expression to emotion-
inducing films in patients with schizophrenia. Archives of Psychiatric Nursing, 25, 
37-47. doi: 10.1016/j.apnu.2011.08.001 
Patel, D. D., Laws, K. R., Padhi, A., Farrow, J. M., Mukhopadhaya, K., … Fineberg, N. 
A. (2010). The neuropsychology of the schizo-obsessive subtype of schizophrenia: 
A new analysis. Psychological Medicine, 40, 921-933. doi: 
10.1017/S0033291709991255 
Paul-Samojedny, M., Kowalczyk, M., Suchanek, R., Owczarek, A., Fila-Danilow, A., … 
Kowalski, J. (2010). Functional polymorphism in the interleukin-6 and interleukin-
10 genes in patients with paranoid schizophrenia--a case-control study. Journal of 
Molecular Neuroscience, 42, 112-119. doi: 10.1007/s12031-010-9365-6 
Pedrosa, E., Nolan, K. A., Stefanescu, R., Hershcovitz, P., Novak, T., … Lachman, H. M. 
(2009). Analysis of a promoter polymorphism in the SMDF neuregulin 1 isoform 
in Schizophrenia. Neuropsychobiology, 59, 205-212. doi: 10.1159/000223732 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Perrin, M. A., Butler, P. D., DiCostanzo, J., Forchelli, G., Silipo, G., & Javitt, D. C. 
(2010). Spatial localization deficits and auditory cortical dysfunction in 
schizophrenia. Schizophrenia Research, 124, 161-168. doi: 
10.1016/j.schres.2010.06.004 
Pietrzak, R. H., Snyder, P. J., Jackson, C. E., Olver, J., Norman, T., … Maruff, P. (2009). 
Stability of cognitive impairment in chronic schizophrenia over brief and 
intermediate re-test intervals. Human Psychopharmacology, 24, 113-121. doi: 
10.1002/hup.998 
Raffard, S., Bayard, S., Gely-Nargeot, M.-C., Capdevielle, D., Maggi, M., … Boulenger, 
J.-P. (2009). Insight and executive functioning in schizophrenia: A 
multidimensional approach. Psychiatry Research, 167, 239-250. doi: 
10.1016/j.psychres.2008.04.018 
Ramakrishnan, M., Sartory, G., van Beekum, A., Lohrmann, T., & Pietrowsky, R. (2012). 
Sleep-related cognitive function and the K-complex in schizophrenia. Behavioural 
Brain Research, 234, 161-166. doi: 10.1016/j.bbr.2012.06.019 
Ramos-Loyo, J., Gonzalez-Garrido, A. A., Sanchez-Loyo, L. M., Medina, V., & Basar-
Eroglu, C. (2009). Event-related potentials and event-related oscillations during 
identity and facial emotional processing in schizophrenia. International Journal of 
Psychophysiology, 71, 84-90. doi: 10.1016/j.ijpsycho.2008.07.008 
Rauch, A. V., Reker, M., Ohrmann, P., Pedersen, A., Bauer, J., … Suslow, T. (2010). 
Increased amygdala activation during automatic processing of facial emotion in 
schizophrenia. Psychiatry Research: Neuroimaging, 182, 200-206. doi: 
10.1016/j.pscychresns.2010.03.005 
Reilly, J. L., Harris, M. S. H., Khine, T. T., Keshavan, M. S., & Sweeney, J. A. (2008). 
Reduced attentional engagement contributes to deficits in prefrontal inhibitory 
control in schizophrenia. Biological Psychiatry, 63, 776-783. doi: 
10.1016/j.biopsych.2007.11.009 
Riedel, M., Spellmann, I., Schennach-Wolff, R., Musil, R., Dehning, S., … Möller, H.-J. 
(2010). Effect of aripiprazole on cognition in the treatment of patients with 
schizophrenia. Pharmacopsychiatry, 43, 50-57. doi: 10.1055/s-0029-1239539 
Ringen, P. A., Vaskinn, A., Sundet, K., Engh, J. A., Jónsdóttir, H., … Andreassen, O. A. 
(2010). Opposite relationships between cannabis use and neurocognitive 
functioning in bipolar disorder and schizophrenia. Psychological Medicine, 40, 
1337-1347. doi: 10.1017/S0033291709991620 
Roberts, D. L., & Penn, D. L. (2009). The effects of task engagement and interpersonal 
rapport on WCST performance in schizophrenia. American Journal of Psychiatric 
Rehabilitation, 12, 57-72. doi: 10.1080/15487760802615798 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Rossi, A., Vita, A., Tiradritti, P., & Romeo, F. (2008). Assessment of clinical and 
metabolic status, and subjective well-being, in schizophrenic patients switched 
from typical and atypical antipsychotics to ziprasidone. International Clinical 
Psychopharmacology, 23, 216-222. doi: 10.1097/YIC.0b013e3282f94905 
Royer, A., Schneider, F. C. G., Grosselin, A., Pellet, J., Barral, F.-G., … Lang, F. (2009). 
Brain activation during executive processes in schizophrenia. Psychiatry Research: 
Neuroimaging, 173, 170-176. doi: 10.1016/j.pscychresns.2009.02.009 
Royer, A., Grosselin, A., Bellot, C., Pellet, J., Billard, S., … Massoubre, C. (2012). Is 
there any impact of cognitive remediation on an ecological test in schizophrenia? 
Cognitive Neuropsychiatry, 17, 19-35. doi: 10.1080/13546805.2011.564512 
Rybakowski, J. K., Dmitrzak-Weglarz, M., Kapelski, P., & Hauser, J. (2012). Functional 
-1149 g/t polymorphism of the prolactin gene in schizophrenia. 
Neuropsychobiology, 21, 350-356. doi: 10.1097/FPC.0b013e32833ee605 
Sánchez, P., Ojeda, N., Peña, J., Elizagárate, E., Yoller, A. B., … Ezcurra, J. (2009). 
Predictors of longitudinal changes in schizophrenia: The role of processing speed. 
Journal of Clinical Psychiatry, 70, 888-896. doi: 10.4088/JCP.08m04294 
Sajatovic, M., Coconcea, N., Ignacio, R. V., Blow, F. C., Hays, R. W., … Meyer,W. J. 
(2008). Adjunct extended-release valproate semisodium in late life schizophrenia. 
International Journal of Geriatric Psychiatry, 23, 142-147. doi: 10.1002/gps.1854 
Scherk, H., Backens, M., Zill, P., Schneider-Axmann, T., Wobrock, T., … Gruber, O. 
(2008). SNAP-25 genotype influences NAA/Cho in left hippocampus. Journal of 
Neural Transmission, 115, 1513-1518. doi: 10.1007/s00702-008-0103-y 
Schiffer, B., Muller, B. W., Scherbaum, N., Forsting, M., Wiltfang, J., … Gizewski, E. 
R. (2010). Impulsivity-related brain volume deficits in schizophrenia-addiction 
comorbidity. Brain, 133, 3093-3103. doi: 10.1093/brain/awq153 
Schimansky, J., David, N., Rössler, W., & Haker, H. (2010). Sense of agency and 
mentalizing: Dissociation of subdomains of social cognition in patients with 
schizophrenia. Psychiatry Research, 178, 39-45. doi: 
10.1016/j.psychres.2010.04.002 
Schlösser, R., Koch, K., Wagner, G., Schultz, C., Röbel, M., … Sauer, H. (2009). 
Intensive practice of a cognitive task is associated with enhanced functional 
integration in schizophrenia. Psychological Medicine, 39, 1809-1819. doi: 
10.1017/S0033291709005820 
Schlagenhauf, F., Juckel, G., Koslowski, M., Kahnt, T., Knutson, B., … Heinz, A. (2008). 
Reward system activation in schizophrenic patients switched from typical 
neuroleptics to olanzapine. Psychopharmacology, 196, 673-684. doi: 
10.1007/s00213-007-1016-4 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Schlagenhauf, F., Wüstenberg, T., Schmack, K., Dinges, M., Wrase, J., … Heinz, A. 
(2008). Switching schizophrenia patients from typical neuroleptics to olanzapine: 
Effects on BOLD response during attention and working memory . European 
Neuropsychopharmacology, 18, 589-599. doi: 10.1016/j.euroneuro.2008.04.013 
Schmauss, M., Jukic, V., Siracusano, A., Bidzan, L., Badescu, G. M., … Schreiner, A. 
(2012). Flexible dosing with paliperidone ER in the treatment of patients with 
acutely exacerbated schizophrenia: Results from a single-arm, open-label study. 
Current Medical Research and Opinion, 28, 1395-1404. doi: 
10.1185/03007995.2012.708327 
Schuhmacher, A., Becker, T., Rujescu, D., Quednow, B. B., Lennertz, L., … Mossner, R. 
(2012). Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in 
the response to antipsychotics. Journal of Psychiatric Research, 46, 1073-1080. 
doi: 10.1016/j.jpsychires.2012.04.021 
Schultz, C. C., Koch, K., Wagner, G., Nenadic, I., Schachtzabel, C., … Schlosser, R. G. 
M. (2012). Reduced anterior cingulate cognitive activation is associated with 
prefrontal-temporal cortical thinning in schizophrenia. Biological Psychiatry, 71, 
146-153. doi: 10.1016/j.biopsych.2011.08.015 
Sehatpour, P., Dias, E. C., Butler, P. D., Revheim, N., Guilfoyle, D. N., … Javitt, D. C. 
(2010). Impaired visual object processing across an occipital-frontal-hippocampal 
brain network in schizophrenia: an integrated neuroimaging study . Archives of 
General Psychiatry, 67, 772-782. doi: 10.1001/archgenpsychiatry.2010.85 
Sharma, E., Raveendranathan, D., Shivakumar, V., Jayaram, N., Rao, N. P., & 
Venkatasubramanian, G. (2012). Beneficial effects of add-on raloxifene in 
schizophrenia: A case report. Archives of Women's Mental Health, 15, 147-148. 
doi: 10.1007/s00737-012-0259-1 
Shin, N. Y., Lee, A. R., Park, H. Y., Yoo, S. Y., Kang, D. H., … Kwon, J. S. (2008). 
Impact of coexistent schizotypal personality traits on frontal lobe function in 
obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & 
Biological Psychiatry, 32, 472-478. doi: 10.1016/j.pnpbp.2007.09.020 
Shur, S., Shamay-Tsoory, S. G., & Levkovitz, Y. (2008). Integration of emotional and 
cognitive aspects of theory of mind in schizophrenia and its relation to prefrontal 
neurocognitive performance. Cognitive Neuropsychiatry, 13, 472-490. doi: 
10.1080/13546800802490034 
Siegle, G. J., Condray, R., Thase, M. E., Keshavan, M., & Steinhauer, S. R. (2010). 
Sustained gamma-band EEG following negative words in depression and 
schizophrenia. International Journal of Psychophysiology, 75, 107-118. doi: 
10.1016/j.ijpsycho.2008.04.008 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Silverstein, S. M., Berten, S., Essex, B., All, S. D., Kasi, R., & Little, D. M. (2010). 
Perceptual organization and visual search processes during target detection task 
performance in schizophrenia, as revealed by fMRI. Neuropsychologia, 48, 2886-
2893. doi: 10.1016/j.neuropsychologia.2010.05.030 
Song, H., & Min, S. K. (2009). Aggressive behavior model in schizophrenic patients. 
Psychiatry Research, 167, 58-95. doi: 10.1016/j.psychres.2008.01.003 
Soštarič, M., & Zalar, B. (2011). The overlap of cognitive impairment in depression and 
schizophrenia: A comparative study. Psychiatria Danubina, 23, 251-256.  
Stenberg, J. H., Terevnikov, V., Joffe, M., Tiihonen, J., Tchoukhine, E., … Joffe, G. 
(2010). Effects of add-on mirtazapine on neurocognition in schizophrenia: a 
double-blind, randomized, placebo-controlled study. International Journal of 
Neuropsychopharmacology, 13, 433-441. doi: 10.1017/S1461145709990897 
Strauss, G. P., Jetha, S. S., Ross, S. A., Duke, L. A., & Allen, D. N. (2010). Impaired 
facial affect labeling and discrimination in patients with deficit syndrome 
schizophrenia. Schizophrenia Research, 118, 146-153. doi: 
10.1016/j.schres.2010.01.016 
Sumiyoshi, T., Tsunoda, M., Higuchi, Y., Itoh, T., Seo, T., … Kurachi, M. (2010). 
Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to 
improve attention in schizophrenia. Advances in Therapy, 27, 307-313. doi: 
10.1007/s12325-010-0035-4 
Takei, K., Yamasue, H., Abe, O., Yamada, H., Inoue, H., … Kasai, K. (2008). Disrupted 
integrity of the fornix is associated with impaired memory organization in 
schizophrenia. Schizophrenia Research, 103, 52-61. doi: 
10.1016/j.schres.2008.03.008 
Takeshi, K., Nemoto, T., Fumoto, M., Arita, H., & Mizuno, M. (2010). Reduced 
prefrontal cortex activation during divergent thinking in schizophrenia: a multi-
channel NIRS study. Progress in Neuro-Psychopharmacology & Biological 
Psychiatry, 34, 1327-1332. doi: 10.1016/j.pnpbp.2010.07.021 
Tang, V. W. K., Leung, S. K., & Lam, L. C. (2008). Clinical correlates of the caregiving 
experience for Chinese caregivers of patients with schizophrenia. Social Psychiatry 
and Psychiatric Epidemiology, 43, 720-726. doi: 10.1007/s00127-008-0357-6 
Tarabeux, J., Champagne, N., Brustein, E., Hamdan, F. F., Gauthier, J., … Rouleau, G. 
A. (2010). De novo truncating mutation in Kinesin 17 associated with 
schizophrenia. Biological Psychiatry, 68, 649-656. doi: 
10.1016/j.biopsych.2010.04.018 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Taylor, S. F., Chen, A. C., Tso, I. F., Liberzon, I., & Welsh, R. C. (2011). Social appraisal 
in chronic psychosis: role of medial frontal and occipital networks . Journal of 
Psychiatric Research, 45, 526-538. doi: 10.1016/j.jpsychires.2010.08.004 
Thirthalli, J., Venkatesh, B. K., Kishorekumar, K. V., Arunachala, U., 
Venkatasubramanian, G., … Gangadhar, B. N. (2009). Prospective comparison of 
course of disability in antipsychotic-treated and untreated schizophrenia patients. 
Acta Psychiatrica Scandinavica, 119, 209-217. doi: 10.1111/j.1600-
0447.2008.01299.x 
Tomasino, B., Bellani, M., Perlini, C., Rambaldelli, G., Cerini, R., … Brambilla, P. 
(2011). Altered microstructure integrity of the amygdala in schizophrenia: A 
bimodal MRI and DWI study. Psychological Medicine, 41, 301-311. doi: 
10.1017/S0033291710000875 
Torgalsboen, A-K., & Rund, B. R. (2010). Maintenance of recovery from schizophrenia 
at 20-year follow-up: what happened? Psychiatry, 73, 70-83. doi: 
10.1521/psyc.2010.73.1.70 
Twamley, E. W., Vella, L., Burton, C. Z., Becker, D. R., Bell, M. D., & Jeste, D. V. 
(2012). The efficacy of supported employment for middle-aged and older people 
with schizophrenia. Schizophrenia Research, 135, 100-104. doi: 
10.1016/j.schres.2011.11.036 
Ucok, A., Incesu, C., Aker, T., & Erkoc, S. (2008). Do psychiatrists examine sexual 
dysfunction in schizophrenia patients? Journal of Sexual Medicine, 5, 2000-2001. 
doi: 10.1111/j.1743-6109.2008.00890.x 
Vaskinn, A., Sundet, K., Friis, S., Ueland, T., Simonsen, C., … Andreassen, O. A. (2008). 
Can learning potential in schizophrenia be assessed with the standard CVLT-II? An 
exploratory study. Scandinavian Journal of Psychology, 49, 179-186. doi: 
10.1111/j.1467-9450.2008.00627.x 
Velligan, D., Brenner, R., Sicuro, F., Walling, D., Riesenberg, R., … Jaeger, J. (2012). 
Assessment of the effects of AZD3480 on cognitive function in patients with 
schizophrenia. Schizophrenia Research, 134, 59-64. doi: 
10.1016/j.schres.2011.10.004 
Vercammen, A., Knegtering, H., Bruggeman, R., & Aleman, A. (2011). Subjective 
loudness and reality of auditory verbal hallucinations and activation of the inner 
speech processing network. Schizophrenia Bulletin, 37, 1009-1016. doi: 
10.1093/schbul/sbq007 
Vercammen, A., Knegtering, H., Liemburg, E. J., den Boer, J. A., & Aleman, A. (2010). 
Functional connectivity of the temporo-parietal region in schizophrenia: effects of 
rTMS treatment of auditory hallucinations. Journal of Psychiatric Research, 44, 
725-731. doi: 10.1016/j.jpsychires.2009.12.011 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Vercammen, A., Morris, R.,  Green, M. J., Lenroot, R.,  Kulkarni, J.,  … Weickert, T. W. 
(2012). Reduced neural activity of the prefrontal cognitive control circuitry during 
response inhibition to negative words in people with schizophrenia . Journal of 
Psychiatry & Neuroscience, 37, 379-388. doi: 10.1503/jpn.110088 
Vierling-Claassen, D., Siekmeier, P., Stufflebeam, S., & Kopell, N. (2008). Modeling 
GABA alterations in schizophrenia: a link between impaired inhibition and altered 
gamma and beta range auditory entrainment. Journal of Neurophysiology, 99, 2656-
2671. doi: 10.1152/jn.00870.2007 
Vuchetich, J. P., Liska, J. L., Dionisio, D. P., Stanwyck, J. J., McGuire, K. A., & 
Sponheim, S. R. (2008). Elevated nailfold plexus visibility aggregates in families 
and is associated with a specific negative symptom pattern in schizophrenia. 
Psychiatry Research, 160, 30-37. doi: 10.1016/j.psychres.2007.04.024 
Walther, S., Federspiel, A., Horn, H., Bianchi, P., Wiest, R., … Muller, T. J. (2009). 
Encoding deficit during face processing within the right fusiform face area in 
schizophrenia. Psychiatry Research, 172, 184-191. doi: 
10.1016/j.pscychresns.2008.07.009 
Wang, Y., Xiang, Y. T., Wang, C. Y., Chiu, H. F. K., Zhao, J. P., … Ungvari, G. S. 
(2011). Insight in Chinese schizophrenia patients: A 12-month follow-up. Journal 
of Psychiatric and Mental Health Nursing, 18, 751-757. doi: 10.1111/j.1365-
2850.2010.01677.x 
Watzke, S., Brieger, P., Kuss, O., Schoettke, H., & Wiedl, K. H. (2008). A longitudinal 
study of learning potential and rehabilitation outcome in schizophrenia. Psychiatric 
Services, 59, 248-255. doi: 10.1176/appi.ps.59.3.248 
Wei, Q., Kang, Z., Diao, F., Shan, B., Li, L., … Zhao, J. (2012). Association of the 
ZNF804A gene polymorphism rs1344706 with white matter density changes in 
Chinese schizophrenia. Progress in Neuro-Psychopharmacology & Biological 
Psychiatry, 36, 122-127. doi: 10.1016/j.pnpbp.2011.08.021 
Wei, Y. L., Li, C. X., Li, S. B., Liu, Y., & Hu, L. (2011). Association study of monoamine 
oxidase A/B genes and schizophrenia in Han Chinese. Behavioral and Brain 
Functions, 7, 42. doi: 10.1186/1744-9081-7-42 
Whitford, T. J., Kubicki, M., Schneiderman, J. S., O'Donnell, L. J., King, R., … Shenton, 
M. E. (2010). Corpus callosum abnormalities and their association with psychotic 
symptoms in patients with schizophrenia. Biological Psychiatry, 68, 70-77. doi: 
10.1016/j.biopsych.2010.03.025 
Xu, M. Q., St Clair, D., Feng, G. Y., Lin, Z. G., He, G., … He, L. (2008). BDNF gene is 
a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced 
extrapyramidal syndrome in the Chinese population. Pharmacogenetics and 
Genomics, 18, 449-457. doi: 10.1097/FPC.0b013e3282f85e26 
This is a postprint of an article published by Springer in Quality of Life Research on 26 December 
2016, available at https://link.springer.com/article/10.1007/s11136-016-1488-y. 
Yoon, J. H., Rokem, A. S., Silver, M. A., Minzenberg, M. J., Ursu, S., … Carter, C. S. 
(2009). Diminished orientation-specific surround suppression of visual processing 
in schizophrenia. Schizophrenia Bulletin, 35, 1078-1084. doi: 
10.1093/schbul/sbp064 
Yu, Q., Sui, J., Rachakonda, S., He, H., Gruner, W., … Calhoun, V. D. (2011). Altered 
topological properties of functional network connectivity in schizophrenia  during 
resting state: a small-world brain network study. PloS one, 6, e25423. doi: 
10.1371/journal.pone.0025423 
Zai, C. C., Tiwari, A. K., Muller, D. J., De Luca, V., Shinkai, T., … Kennedy, J. L. (2010). 
The catechol-O-methyl-transferase gene in tardive dyskinesia. The World Journal 
of Biological Psychiatry, 11, 803-812. doi: 10.3109/15622975.2010.486043 
Zalesky, A., Fornito, A., Seal, M. L., Cocchi, L., Westin, C. F., … Pantelis, C. (2011). 
Disrupted axonal fiber connectivity in schizophrenia. Biological Psychiatry, 69, 80-
89. doi: 10.1016/j.biopsych.2010.08.022 
Zandbelt, B. B., van Buuren, M., Kahn, R. S., & Vink, M. (2011). Reduced proactive 
inhibition in schizophrenia is related to corticostriatal dysfunction and poor 
working memory. Biological Psychiatry, 70, 1151-1158. doi: 
10.1016/j.biopsych.2011.07.028 
Zhang, C., Xie, B., Du, Y., Cheng, W., Fang, Y., & Yu, S. (2010). Further evidence that 
methylenetetrahydrofolate reductase A1298C polymorphism is a risk factor for 
schizophrenia. Journal of Neural Transmission, 117, 1115-1117. doi: 
10.1007/s00702-010-0442-3 
Zhou, Y., Wang, J., Wang, K., Li, S., Song, X., … Ying, B. (2010). Association analysis 
between the rs11136000 single nucleotide polymorphism in clusterin gene, 
rs3851179 single nucleotide polymorphism in clathrin assembly lymphoid myeloid 
protein gene and the patients with schizophrenia in the Chinese population. DNA 
and Cell Biology, 29, 745-751. doi: 10.1089/dna.2010.1075 
Zilles, D., Gruber, E., Falkai, P., & Gruber, O. (2010). Patients with schizophrenia show 
deficits of working memory maintenance components in circuit-specific tasks. 
European Archives of Psychiatry and Clinical Neuroscience, 260, 519-525. doi: 
10.1007/s00406-010-0107-0 
Zou, M., Li, D., Lv, R., Zhou, Y., Wang, T., & Wang, L. (2012). Association between 
two single nucleotide polymorphisms at corresponding microRNA and 
schizophrenia in a Chinese population. Molecular Biology Reports, 39, 3385-3391. 
doi: 10.1007/s11033-011-1109-3 
 
